Description

Stiripentol (Wx692001) is a high-purity pharmaceutical active ingredient with the CAS registry number 137767-55-6. This compound is a critical agent in the development and manufacturing of advanced antiepileptic therapies, valued for its specific mechanism of action. It is primarily required by pharmaceutical manufacturers and research institutions engaged in neurology and CNS drug development.

Application

• Pharmaceutical Active Ingredient (API): Primary use in the formulation of antiepileptic medications, specifically for the treatment of Dravet syndrome.
• Neurological Research: A key compound in preclinical and clinical research focused on seizure disorders and GABAergic neurotransmission.
• Reference Standard: Serves as a high-purity analytical standard for quality control and method validation in pharmaceutical laboratories.
• Drug Development Intermediary: Used in the synthesis and development of new therapeutic entities targeting similar neurological pathways.
• Clinical Trial Material (CTM): Supplied under GMP conditions for use in clinical studies and trials.

Basic Information

Product Name	Stiripentol (Wx692001)
CAS No.	137767-55-6
Molecular Formula	C14H18O3
Molecular Weight	234.29 g/mol
Synonyms	Stiripentol; Diacomit; (1-[(2,4-Dichlorophenyl)(1H-1,2,4-triazol-1-yl)methyl]propyl) Carbamate; BCX 2600; 4,4-Dimethyl-1-(3,4-methylenedioxyphenyl)-1-penten-3-ol; STP
EINECS	Contact for details

Quality Control

Our Stiripentol is manufactured and tested to meet stringent pharmaceutical-grade standards. Quality assurance protocols are designed to ensure identity, purity, strength, and composition, with a focus on compliance with ICH guidelines. A comprehensive Certificate of Analysis (COA) detailing specific results for all release tests, including assay and impurity profiles by HPLC, is provided with each batch.

Storage

Preserve in a tightly closed container, protected from light. Store in a cool, dry place at controlled room temperature (15-25°C). Due to its hygroscopic nature, the container must be kept tightly sealed in a dry environment to prevent moisture absorption.

Specification

Item	Specification
Appearance	White to off-white crystalline powder
Identification (IR)	Conforms to reference spectrum
Identification (HPLC)	Retention time corresponds to reference standard
Assay (HPLC)	98.0% - 102.0% (on anhydrous basis)
Water Content (KF)	≤ 0.5%
Related Substances (HPLC)	Total impurities ≤ 1.0% Any individual impurity ≤ 0.5%
Residual Solvents (GC)	Complies with ICH Q3C guidelines
Heavy Metals	≤ 20 ppm

Note: Specifications can be tailored. Please contact us for the detailed technical data sheet of a specific grade.